iNtRON Biotechnology Market Cap

iNtRON Biotechnology has a market cap or net worth of 120.13 billion as of June 23, 2025. Its market cap has decreased by -41.72% in one year.

Market Cap

120.13B

Enterprise Value

75.39B

Revenue

5.69B

Ranking

n/a

PE Ratio

n/a

Stock Price

3,850.00

Market Cap Chart

Since January 26, 2011, iNtRON Biotechnology's market cap has increased from 95.30B to 120.13B, an increase of 26.06%. That is a compound annual growth rate of 1.62%.

Market Cap History

Date	Market Cap	% Change
Jun 20, 2025	123.77B	-32.57%
Dec 30, 2024	183.56B	-37.01%
Dec 28, 2023	291.42B	7.98%
Dec 29, 2022	269.88B	-61.99%
Dec 30, 2021	710.00B	-22.41%
Dec 30, 2020	915.06B	97.15%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	72.31T
Celltrion	35.87T
ALTEOGEN	20.84T
Yuhan	7,750.90B
SK Biopharmaceuticals	7,275.30B
HLB Co., Ltd.	7,017.40B
PharmaResearch	4,748.07B
Peptron	4,647.82B

Market Cap Rankings